Works matching IS 17762596 AND DT 2016 AND VI 11 AND IP 3
Results: 15
Acceleration of Proteinuria without Significant Impact on Renal Function and Its Protection by Angiotensin II Receptor Blocker in Rats Treated with Axitinib.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Phase 1 Study of Monotherapy with KHK2866, an Anti-Heparin-Binding Epidermal Growth Factor-Like Growth Factor Monoclonal Antibody, in Patients with Advanced Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Changes in Renal Function of Patients with Metastatic Renal Cell Carcinoma During Treatment with Molecular-Targeted Agents.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Magnitude of PD-1, PD-L1 and T Lymphocyte Expression on Tissue from Castration-Resistant Prostate Adenocarcinoma: An Exploratory Analysis.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal Cancer.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Afatinib, an Irreversible EGFR Family Inhibitor, Shows Activity Toward Pancreatic Cancer Cells, Alone and in Combination with Radiotherapy, Independent of KRAS Status.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Rare RAS Mutations in Metastatic Colorectal Cancer Detected During Routine RAS Genotyping Using Next Generation Sequencing.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Systematic Review of the Side Effects Associated With Anti-HER2-Targeted Therapies Used in the Treatment of Breast Cancer, on Behalf of the EORTC Quality of Life Group.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Targeted Therapies for the Treatment of Brain Metastases in Solid Tumors.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Erratum to: Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy.
- Published in:
- 2016
- By:
- Publication type:
- Erratum
An Adaptive Study to Determine the Optimal Dose of the Tablet Formulation of the PARP Inhibitor Olaparib.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Dabrafenib plus Trametinib: a Review in Advanced Melanoma with a BRAF (V600) Mutation.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Heterodimeric Bispecific Single Chain Variable Fragments (scFv) Killer Engagers (BiKEs) Enhance NK-cell Activity Against CD133+ Colorectal Cancer Cells.
- Published in:
- 2016
- By:
- Publication type:
- journal article